Therapeutic evaluation of Unani formulations and leeching in patients of Psoriasis
Phase 3
- Conditions
- Health Condition 1: PCS- Health Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2021/10/037022
- Lead Sponsor
- Department of Amraze jild wa Zohrawiya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of plaque psoriasis controlled clinically
Clinically stable patients
Patients having age group of 14-60 years
Patients of either sex
Patients not on any concomitant therapy
Patients who has left the treatment at least 2 months back
Patients agreed and signed the written consent proforma
Exclusion Criteria
Doubtful cases of plaque psoriasis
Plaque psoriasis with systemic illnesses like diabetes mellitus, chronic liver diseases etc.
Plaque psoriasis with secondary infection
Immunocompromised patients
Patients below the age of 14 years and above the age of 60 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in erythema, scaling, itching and thickness of lesions.Timepoint: Improvement in itching - 4 weeks <br/ ><br>Improvement in erythema, scaling and thickness of lesions - 8 weeks
- Secondary Outcome Measures
Name Time Method PASI score <br/ ><br>PGATimepoint: Monthly interval for a period of 6 months